3 months ago
RVMD
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 6%
#291 out of 5337 analysts
Average Return
+60.29%
Win Rate
69%24 out of 35
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +395.13% | $36.54 | $180.92 | 2025-08-19 - 2026-07-29 | Strong Buy |
Century Therapeutics IncIPSC | +336.04% | $0.56 | $2.42 | 2025-03-21 - 2026-03-20 | Strong Buy |
Erasca IncERAS | +242.75% | $5.17 | $17.72 | 2026-01-07 - 2026-07-29 | Strong Buy |
Tango Therapeutics IncTNGX | +195.40% | $6.96 | $20.56 | 2025-08-19 - 2026-05-15 | Strong Buy |
Cg Oncology IncCGON | +170.42% | $25.56 | $69.12 | 2025-08-19 - 2026-07-29 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
5 months ago
ERAS
5 months ago
RVMD
6 months ago
TNGX
6 months ago
ERAS
6 months ago
CGON
9 months ago
DAWN
9 months ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Leonabio IncLONA | 1 | Strong Buy | $20.00 | +184.09% | Initiates Coverage On | 2 months ago |
Tango Therapeutics IncTNGX | 3 | Hold | $24.00 | -7.16% | Downgrades | 3 months ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $26.00 | +73.80% | Maintains | 3 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $172.00 | -4.93% | Maintains | 3 months ago |
Summit Therapeutics IncSMMT | 2 | Hold | $16.00 | +25.00% | Maintains | 3 months ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $12.00 | +133.46% | Initiates Coverage On | 4 months ago |
Erasca IncERAS | 3 | Strong Buy | $18.00 | +1.58% | Maintains | 5 months ago |
Arcellx IncACLX | 3 | Hold | $115.00 | -0.06% | Downgrades | 5 months ago |
Cg Oncology IncCGON | 2 | Strong Buy | $70.00 | +1.27% | Maintains | 6 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +381.93% | Maintains | 6 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +529.92% | Initiates Coverage On | 7 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +95.04% | Initiates Coverage On | 7 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +20.76% | Maintains | 9 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +3.26% | Maintains | 9 months ago |
Urogen Pharma LtdURGN | 3 | Strong Buy | $36.00 | -11.00% | Initiates Coverage On | a year ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | +39.05% | Initiates Coverage On | a year ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.